UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 6,197 Shares of HealthEquity, Inc. (NASDAQ:HQY)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 1.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 329,477 shares of the company's stock after purchasing an additional 6,197 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.38% of HealthEquity worth $26,968,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. GSA Capital Partners LLP acquired a new position in shares of HealthEquity in the third quarter worth about $638,000. Vaughan Nelson Investment Management L.P. grew its position in HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock worth $69,034,000 after purchasing an additional 226,563 shares in the last quarter. Natixis Advisors LLC raised its stake in HealthEquity by 29.8% during the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock valued at $17,122,000 after purchasing an additional 48,009 shares during the period. Oppenheimer Asset Management Inc. lifted its holdings in shares of HealthEquity by 29.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company's stock valued at $5,535,000 after purchasing an additional 14,573 shares in the last quarter. Finally, Diversify Wealth Management LLC acquired a new stake in shares of HealthEquity in the second quarter worth $8,182,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Price Performance

HQY traded down $1.01 during midday trading on Thursday, reaching $101.99. 211,804 shares of the company's stock were exchanged, compared to its average volume of 623,196. HealthEquity, Inc. has a one year low of $62.10 and a one year high of $105.82. The firm has a market capitalization of $8.91 billion, a price-to-earnings ratio of 85.83, a price-to-earnings-growth ratio of 1.59 and a beta of 0.55. The business has a 50-day simple moving average of $91.57 and a two-hundred day simple moving average of $83.31. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. As a group, research analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. BTIG Research upped their price target on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday, November 14th. JMP Securities reissued a "market outperform" rating and issued a $105.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Royal Bank of Canada reiterated an "outperform" rating and issued a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, Bank of America boosted their price target on shares of HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $109.64.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the company's stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company's stock, valued at approximately $4,540,582.62. This represents a 13.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,039 shares of the stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares in the company, valued at $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is owned by insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.